Priority 14 from the Mesothelioma PSP
| UNCERTAINTY: Is giving a course of chemotherapy to mesothelioma patients before or after surgery beneficial? (JLA PSP Priority 14) | |
|---|---|
| Overall ranking | 14 |
| JLA question ID | 0025/14 |
| Explanatory note | Not available for this PSP |
| Evidence | No systematic reviews or studies identified |
| Health Research Classification System category | Cancer |
| Extra information provided by this PSP | |
|---|---|
| Original uncertainty examples | We had to pay privately for chemotherapy pre op with Pemetrexed as this was said not to be available for potentially curative treatments only if it was palliative! |
| Comparison | Surgery |
| Submitted by | Carer |
| Outcomes to be measured | Survival |
| PSP information | |
|---|---|
| PSP unique ID | 0025 |
| PSP name | Mesothelioma |
| Total number of uncertainties identified by this PSP. | 53 (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website) |
| Date of priority setting workshop | 16 December 2014 |